Categories Uncategorized

Brain Scientific Inc.’s (BRSF) Marketing Director Interviewed for One of Top News Source for Startups

  • Irina Nazarova, Brain Scientific’s marketing director, interviewed for Grit Daily, one of the top news hubs for startups, discussing exciting new product developments the company is working on
  • BRSF is poised to extend the universe of EEG use cases, expanding possible markets for its disruptive products

Irina Nazarova, marketing director of Brain Scientific (OTCQB: BRSF), was interviewed for Grit Daily News, the top news source on Millennial and Gen Z startups, where she presented the latest work that the company does in the space of neurology medical devices (https://ibn.fm/CeYY3). Nazarova, who has significant marketing experience as the former Editor-in-Chief at the largest entertainment magazine in Russia, discussed with Daniela Elezovic of Grit Daily, the exciting neurological advancements made possible by the work of Brain Scientific and how the company works toward expanding what is possible in neurology space.

Nazarova highlights products that the company has developed in the EEG space: NeuroCap, a ready-to-use and disposable EEG headset that allows any member of medical staff to perform routine EEG testing within minutes, and NeuroEEG, portable, wireless and miniature amplifier. NeuroCap aims to disrupt the current slow and cumbersome EEG testing and bring cost-effective yet high-quality alternatives in what Nazarova describes conservative industry.

Traditionally, the use of EEG was limited to the medical or scientific settings where the device established itself as the gold standard for diagnosing conditions such as epilepsy. However, recent trends open the door for leveraging the power of the device beyond traditional settings to include applications related to our daily experiences such as in education, sleep, e-sports, meditation, and many more. The list of possible applications where EEG could be used is virtually limitless — it can improve any area of our lives.

As Nazarova concludes, the technology does not have boundaries — and Brain Scientific continues to develop breakthroughs that enhance people’s lives.

For more information, visit the company’s website at www.BrainScientific.com/Invest-Now.

NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at https://ibn.fm/BRSF

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.biomedwire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.biomedwire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Chris@BMW

Share
Published by
Chris@BMW

Recent Posts

Soligenix Inc. (NASDAQ: SNGX) Driving Innovation in Photodynamic Therapy Potential in Oncology, Dermatology

One of the key advantages of photodynamic therapy is its selectivity. Soligenix is advancing HyBryte(TM),…

1 day ago

Why the Cost of Health Care in the US is Soaring

While people have been quick to blame health insurers for the skyrocketing cost of health…

1 day ago

LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT) Aligns Liora and the LiGHT System With LB-100 to Push the Frontier of Cancer Treatment

LIXTE Biotechnology recently acquired Liora Technologies, and the acquisition includes Liora’s proprietary LiGHT system This…

2 days ago

New Photodynamic Therapy Offers Hope Against Brain Cancer

A planned preclinical study testing a light-activated therapy that helps to kill residual brain cancer cells after…

5 days ago

Novel Yeast Cell Platform Promises to Expedite the Development of Immunotherapies

Researchers have developed a technological platform that leverages yeast cells to test and understand new cancer treatments…

6 days ago

The Anti-Dilution Playbook: How Earth Science Tech Inc. (ETST) Rewrote the OTC Capital Structure Narrative

The company has issued zero common shares since October 2023, marking a decisive break from…

6 days ago